Detalhe da pesquisa
1.
Genetic Adaptation and Neandertal Admixture Shaped the Immune System of Human Populations.
Cell;
167(3): 643-656.e17, 2016 Oct 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27768888
2.
Dissecting human population variation in single-cell responses to SARS-CoV-2.
Nature;
621(7977): 120-128, 2023 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37558883
3.
Human Immunity and Susceptibility to Influenza A(H3) Viruses of Avian, Equine, and Swine Origin.
Emerg Infect Dis;
29(1): 98-109, 2023 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36573615
4.
A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus.
J Infect Dis;
225(8): 1399-1410, 2022 04 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32313928
5.
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials.
Lancet;
397(10268): 39-50, 2021 01 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33308429
6.
Safety and Immunogenicity of a Second Dose of an Investigational Maternal Trivalent Group B Streptococcus Vaccine in Nonpregnant Women 4-6 Years After a First Dose: Results From a Phase 2 Trial.
Clin Infect Dis;
70(12): 2570-2579, 2020 06 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31394574
7.
Detection of H1 Swine Influenza A Virus Antibodies in Human Serum Samples by Age Group1.
Emerg Infect Dis;
26(9): 2118-2128, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32818398
8.
Immunogenicity and Safety of 3 Formulations of a Respiratory Syncytial Virus Candidate Vaccine in Nonpregnant Women: A Phase 2, Randomized Trial.
J Infect Dis;
220(11): 1816-1825, 2019 10 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31418022
9.
Persistence of HBsAg-specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults.
J Viral Hepat;
26(9): 1066-1075, 2019 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31087382
10.
Safety and Immunogenicity of Different Formulations of Norovirus Vaccine Candidate in Healthy Adults: A Randomized, Controlled, Double-Blind Clinical Trial.
J Infect Dis;
217(4): 597-607, 2018 01 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29140444
11.
Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver.
Gut;
66(5): 920-929, 2017 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27006186
12.
Monoclonal anti-envelope antibody AP33 protects humanized mice against a patient-derived hepatitis C virus challenge.
Hepatology;
63(4): 1120-34, 2016 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26710081
13.
Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice.
Gut;
65(12): 2029-2034, 2016 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26306759
14.
Generation and characterization of small single domain antibodies inhibiting human tumor necrosis factor receptor 1.
J Biol Chem;
290(7): 4022-37, 2015 Feb 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25538244
15.
Impact of adjuvants on CD4(+) T cell and B cell responses to a protein antigen vaccine: Results from a phase II, randomized, multicenter trial.
Clin Immunol;
169: 16-27, 2016 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27236001
16.
A monoclonal antibody-based immunoassay to measure the antibody response against the repeat region of the circumsporozoite protein of Plasmodium falciparum.
Malar J;
15(1): 543, 2016 Nov 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27825382
17.
In vitro and in vivo metabolism studies of dimethazine.
Biomed Chromatogr;
30(8): 1202-9, 2016 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26663462
18.
Anti-CD81 but not anti-SR-BI blocks Plasmodium falciparum liver infection in a humanized mouse model.
J Antimicrob Chemother;
70(6): 1784-7, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25656410
19.
Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses.
J Virol;
88(10): 5502-10, 2014 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24599994
20.
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents.
Hepatology;
60(5): 1508-18, 2014 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24797654